Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE studyOliver A. Cornely, Sílvia Gómez-Zorrilla, Boudewijn de Jonge et al.|Journal of Antimicrobial Chemotherapy|2019Cited by 123
Dose selection for aztreonam-avibactam, including adjustments for renal impairment, for Phase IIa and Phase III evaluationShampa Das, Susan Raber, James G. Wright et al.|European Journal of Clinical Pharmacology|2024Cited by 28
Dose selection for aztreonam-avibactam, including adjustments for renal impairment, for phase IIa and phase III evaluationShampa Das, Susan Raber, James G. Wright et al.|Research Square|2023Cited by 0